Lurasidone for the treatment of bipolar depression: an evidence-based review.

Abstract:

:Bipolar disorder (BD) is a debilitating and difficult-to-treat psychiatric disease that presents a serious burden to patients' lives as well as health care systems around the world. The essential diagnostic criterion for BD is episodes of mania or hypomania; however, the patients report that the majority of their time is spent in a depressive phase. Current treatment options for this component of BD have yet to achieve satisfactory remission rates. Lurasidone is a drug in the benzisothiazole class approved by the US Food and Drug Administration in June 2013 for the acute treatment of bipolar depression. Its pharmacological profile features high-affinity antagonism at D2, 5-HT2A, and 5-HT7 receptors; moderate-affinity antagonism at α2C-adrenergic receptors; low- to very low-affinity antagonism at α1A-adrenergic, α2A-adrenergic, H1, M1, and 5-HT2C receptors; and high-affinity partial agonism at 5-HT1A. Preliminary findings from two recent double-blinded clinical trials suggest that lurasidone is efficacious in treating bipolar I depression, with clinical effects manifesting as early as the first 2-3 weeks of treatment (as measured by the Montgomery-Åsberg Depression Rating Scale and Clinical Global Impressions Scale for use in bipolar illness). Its therapeutic benefit appears to be comparable to the current US Food and Drug Administration-indicated treatments: quetiapine and olanzapine-fluoxetine, according to a measure of effect size known as number needed to treat. These studies reported relatively limited extrapyramidal and metabolic side effects as a result of treatment with lurasidone, with the most common side effect being nausea. Safety data drawn from these studies, as well as a more extensive body of schizophrenia research, indicate that in comparison with other atypical antipsychotics, treatment with lurasidone is less likely to result in metabolic side effects such as weight gain or disturbances of serum glucose or lipid levels. Lurasidone holds clinical potential as a novel, efficacious pharmacological treatment for bipolar depression. However, current data on its use for the treatment of BD are limited, and more extensive research, both longer in duration as well as independently conducted, is needed.

authors

Franklin R,Zorowitz S,Corse AK,Widge AS,Deckersbach T

doi

10.2147/NDT.S50961

subject

Has Abstract

pub_date

2015-08-19 00:00:00

pages

2143-52

eissn

1176-6328

issn

1178-2021

pii

ndt-11-2143

journal_volume

11

pub_type

杂志文章,评审
  • Influence of trait anxiety, child maltreatment, and adulthood life events on depressive symptoms.

    abstract:Background:Various personality traits mediate the association between childhood stress and depressive symptoms in adulthood. The aim of this study was to clarify the indirect effects of the experience of child maltreatment on depressive symptoms and appraisal of life events in adulthood through trait anxiety. Subjects...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S182783

    authors: Uchida Y,Takahashi T,Katayama S,Masuya J,Ichiki M,Tanabe H,Kusumi I,Inoue T

    更新日期:2018-11-27 00:00:00

  • Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population.

    abstract:Purpose:This randomized, double-blind (DB), non-inferiority phase 3 study was conducted to assess the efficacy and safety of paliperidone palmitate 3-month (PP3M) vs 1-month formulation (PP1M) in European and non-European patients with schizophrenia. Patients and methods:In this randomized, DB, parallel-group study, a...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S189668

    authors: Savitz AJ,Xu H,Gopal S,Nuamah I,Ravenstijn P,Hough D,Hargarter L

    更新日期:2019-02-21 00:00:00

  • Prefrontoparietal dysfunction during emotion regulation in anxiety disorder: a meta-analysis of functional magnetic resonance imaging studies.

    abstract:Objective:Impairments in emotion regulation, and more specifically in cognitive reappraisal, are thought to play a key role in the pathogenesis of anxiety disorders. However, the available evidence on such deficits is inconsistent. To further illustrate the neurobiological underpinnings of anxiety disorder, the present...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S165677

    authors: Wang HY,Zhang XX,Si CP,Xu Y,Liu Q,Bian HT,Zhang BW,Li XL,Yan ZR

    更新日期:2018-05-09 00:00:00

  • Disconnection of the hippocampus and amygdala associated with lesion load in relapsing-remitting multiple sclerosis: a structural and functional connectivity study.

    abstract:BACKGROUND AND PURPOSE:Little is known about the functional and structural connectivity (FC and SC) of the hippocampus and amygdala, which are two important structures involved in cognitive processes, or their involvement in relapsing-remitting multiple sclerosis (RRMS). In this study, we aimed to examine the connectiv...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S84602

    authors: Zhou F,Zhuang Y,Wang L,Zhang Y,Wu L,Zeng X,Gong H

    更新日期:2015-07-17 00:00:00

  • Optimal management of night eating syndrome: challenges and solutions.

    abstract::Night Eating Syndrome (NES) is a unique disorder characterized by a delayed pattern of food intake in which recurrent episodes of nocturnal eating and/or excessive food consumption occur after the evening meal. NES is a clinically important disorder due to its relationship to obesity, its association with other psychi...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S70312

    authors: Kucukgoncu S,Midura M,Tek C

    更新日期:2015-03-19 00:00:00

  • Fluvoxamine in the treatment of anxiety disorders.

    abstract::Fluvoxamine is a selective-serotonin reuptake inhibitor (SSRI) that has proved effective in large double-blind, randomized, controlled trials involving patients with social anxiety disorder (SAD), obsessive-compulsive disorder (OCD), and panic disorder. Improvements have also been demonstrated in patients with post-tr...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:

    authors: Irons J

    更新日期:2005-12-01 00:00:00

  • Transcranial magnetic stimulation for the treatment of anxiety disorder.

    abstract::Anxiety is currently one of the main mood changes and can impair the quality of life of the individual when associated with other neurological or psychiatric disorders. Neuromodulation has been highlighted as a form of treatment of several pathologies, including those involving anxiety symptoms. Among the neuromodulat...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S201407

    authors: Rodrigues PA,Zaninotto AL,Neville IS,Hayashi CY,Brunoni AR,Teixeira MJ,Paiva WS

    更新日期:2019-09-23 00:00:00

  • Deep brain stimulation in Tourette's syndrome: evidence to date.

    abstract::Tourette's syndrome (TS) is a neurodevelopmental disorder that comprises vocal and motor tics associated with a high frequency of psychiatric comorbidities, which has an important impact on quality of life. The onset is mainly in childhood and the symptoms can either fade away or require pharmacological therapies asso...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S139368

    authors: Casagrande SCB,Cury RG,Alho EJL,Fonoff ET

    更新日期:2019-04-29 00:00:00

  • Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients.

    abstract:OBJECTIVE:To investigate the impact of anxiety symptoms on depression outcomes in Asian patients with major depressive disorder (MDD) (n=714). METHODS:The 17-item Hamilton Depression Scale (HAMD-17), overall severity, somatic symptoms, and quality of life (QOL) (EuroQOL Questionnaire-5 Dimensions [EQ-5D]) were assesse...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S90134

    authors: Novick D,Montgomery W,Aguado J,Peng X,Haro JM

    更新日期:2016-04-11 00:00:00

  • Orthostatic hypotension and dementia incidence: links and implications.

    abstract::Orthostatic hypotension (OH) is a common condition, particularly in patients with α-synucleinopathies such as Parkinson's disease, and has a significant impact on activities of daily living and quality of life. Recent data suggest an association with cognitive impairment. Herein, we review the evidence that OH increas...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S182123

    authors: Robertson AD,Udow SJ,Espay AJ,Merola A,Camicioli R,Lang AE,Masellis M

    更新日期:2019-08-02 00:00:00

  • Disease-modifying therapies in relapsing-remitting multiple sclerosis.

    abstract:CLINICAL QUESTION:What is the best current disease-modifying therapy for relapsing-remitting multiple sclerosis? RESULTS:The evidence shows that the most effective disease-modifying therapy for delaying short- to medium-term disability progression, prevention of relapses, reducing the area and activity of lesions on m...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s11079

    authors: González-Andrade F,Alcaraz-Alvarez JL

    更新日期:2010-09-07 00:00:00

  • Suicidal behavior among Turkish patients with Parkinson's disease.

    abstract:OBJECTIVE:To investigate the predictors of suicidal ideation and attempts among Turkish Parkinson's disease (PD) patients. MATERIALS AND METHODS:The study comprised 120 patients with PD. Clinical findings were obtained by using the Unified Parkinson's Disease Rating Scale. Disease severity was measured by the Hoehn an...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S60450

    authors: Ozdilek B,Gultekin BK

    更新日期:2014-03-26 00:00:00

  • Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study.

    abstract:BACKGROUND:Escitalopram is a selective serotonin reuptake inhibitor, widely used in the treatment of affective disorders. The purpose of this study was to examine its safety and tolerability, as mono- versus augmentative therapy, in a group of patients with affective disorders. MATERIALS AND METHODS:The sample consist...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S39322

    authors: Dell'osso B,Arici C,Dobrea C,Camuri G,Benatti B,Altamura AC

    更新日期:2013-01-01 00:00:00

  • Complex obsessive compulsive and impulsive symptoms in Tourette's syndrome.

    abstract::Obsessive compulsive and impulsive symptoms are prevalent in patients with Tourette's Syndrome (TS) and well recognized as part of the TS spectrum. However, some complex obsessive compulsive and impulsive behaviors may be mistaken for other symptoms, such as complex tics or psychotic behavior. In addition, the overlap...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:

    authors: Palumbo D,Kurlan R

    更新日期:2007-01-01 00:00:00

  • Comparison of clinical features between primary and drug-induced sleep-related eating disorder.

    abstract:PURPOSE:The aim of this study was to ascertain the clinical characteristics of drug-induced sleep-related eating disorder (SRED). PATIENTS AND METHODS:We retrospectively reviewed the medical records of 30 patients with primary SRED (without any comorbid sleep disorders and who were not taking any possible causative me...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S107462

    authors: Komada Y,Takaesu Y,Matsui K,Nakamura M,Nishida S,Kanno M,Usui A,Inoue Y

    更新日期:2016-05-26 00:00:00

  • Rehabilitation for a child with recalcitrant anti-N-methyl-d-aspartate receptor encephalitis: case report and literature review.

    abstract::Anti-N-methyl-d-aspartate (anti-NMDA) receptor encephalitis is a newly recognized, potentially fatal, but treatable autoimmune disease. Good outcome predictors include milder severity of symptoms, no need for intensive care unit admission, early aggressive immunotherapy, and prompt tumor removal. We report a case of a...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:10.2147/NDT.S74205

    authors: Guo YH,Kuan TS,Hsieh PC,Lien WC,Chang CK,Lin YC

    更新日期:2014-11-24 00:00:00

  • Comorbidity between obsessive-compulsive disorder and body dysmorphic disorder: prevalence, explanatory theories, and clinical characterization.

    abstract:BACKGROUND:With the advent of the fifth edition of Diagnostic and Statistical Manual of Mental Disorders, body dysmorphic disorder (BDD) has been subsumed into the obsessive-compulsive disorders and related disorders (OCDRD) category. OBJECTIVE:We aimed to determine the empirical evidence regarding the potential relat...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S67636

    authors: Frías Á,Palma C,Farriols N,González L

    更新日期:2015-08-26 00:00:00

  • A preliminary study of Patient Dignity Inventory validation among patients hospitalized in an acute psychiatric ward.

    abstract:PURPOSE:To investigate the perception of dignity among patients hospitalized in a psychiatric setting using the Patient Dignity Inventory (PDI), which had been first validated in oncologic field among terminally ill patients. PATIENTS AND METHODS:After having modified two items, we administered the Italian version of ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S122423

    authors: Di Lorenzo R,Cabri G,Carretti E,Galli G,Giambalvo N,Rioli G,Saraceni S,Spiga G,Del Giovane C,Ferri P

    更新日期:2017-01-23 00:00:00

  • Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach.

    abstract:Purpose:This study aims to evaluate the quality of the Finnish clinical practice guideline related to schizophrenia care and how it can be utilized in psychiatric services. Participants and methods:The data were collected from one psychiatric ward and seven psychiatric outpatient units situated in two cities in Southe...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S192752

    authors: Vähäniemi A,Välimäki M,Pekurinen V,Anttila M,Lantta T

    更新日期:2019-05-09 00:00:00

  • Productivity and deadweight losses due to relapses of schizophrenia in Japan.

    abstract:BACKGROUND:No study has examined the financial impact of relapses on schizophrenia from the perspective of Japanese society. This study aimed to estimate the societal costs in Japan caused by the relapses of schizophrenia. METHODS:The societal costs in Japan in 2013 due to relapses of schizophrenia were estimated by s...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S138033

    authors: Nakamura Y,Mahlich J

    更新日期:2017-05-17 00:00:00

  • Predictors of sleep disturbance in heroin users receiving methadone maintenance therapy: a naturalistic study in Taiwan.

    abstract:Introduction:Sleep disturbance is a major health concern for heroin users receiving methadone maintenance treatment (MMT). The present study was aimed to investigate the predictors for new-onset clinically predominant sleep disturbance (CPSD) among heroin users receiving MMT. Methods:This 2-year retrospective study in...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S177370

    authors: Li DJ,Chung KS,Wu HC,Hsu CY,Yen CF

    更新日期:2018-10-26 00:00:00

  • Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis.

    abstract:Goal:The goal of this study was to explore the impact of self-stigma on the treatment outcomes in patients with anxiety disorders and to find possible mediators of this relationship. Method:Two hundred and nine patients with anxiety disorders, who were hospitalized in a psychotherapeutic department, attended the study...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S152208

    authors: Ociskova M,Prasko J,Vrbova K,Kasalova P,Holubova M,Grambal A,Machu K

    更新日期:2018-01-26 00:00:00

  • Undertreatment of human immunodeficiency virus in psychiatric inpatients: a cross-sectional study of seroprevalence and associated factors.

    abstract:BACKGROUND:The aims of this study were to evaluate the prevalence of HIV and its associated demographic and clinical factors among psychiatric inpatients of a general hospital. METHODS:This was a single-center, observational, cross-sectional study that included patients consecutively admitted to our unit aged 16 years...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S79939

    authors: Gonzalez-Torres MA,Salazar MA,Imaz M,Inchausti L,Ibañez B,Fernandez-Rivas A,Pastor J,Anguiano B,Muñoz P,Ruiz E,Oraa R,Bustamante S,de Eulate SA,Cisterna R

    更新日期:2015-06-11 00:00:00

  • Secondary central nervous system lymphoma: spectrum of morphological MRI appearances.

    abstract:Background:Secondary central nervous system lymphoma (SCNSL) is a rare and aggressive disease, which is defined as secondary central nervous system (CNS) involvement in patients with systemic lymphoma. According to previous reports, SCNSL presents mostly with leptomeningeal spread; however, our experience differs. In t...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S157959

    authors: Malikova H,Burghardtova M,Koubska E,Mandys V,Kozak T,Weichet J

    更新日期:2018-03-12 00:00:00

  • Affect regulation: a systems neuroscience perspective.

    abstract:OBJECTIVE:TO INTEGRATE: (1) the neuroanatomical model of affect regulation; (2) a functional model of affect regulation; and (3) the evolving picture of affect dysregulation as exemplified by bipolar disorder. METHODOLOGY:A computerized search for articles on related topics was augmented by additional selected studies...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/nedt.1.1.9.52299

    authors: Pavuluri MN,Herbener ES,Sweeney JA

    更新日期:2005-03-01 00:00:00

  • Long noncoding RNA CASC2 predicts the prognosis of glioma patients and functions as a suppressor for gliomas by suppressing Wnt/β-catenin signaling pathway.

    abstract:BACKGROUND:Previous studies have demonstrated that long noncoding RNA cancer susceptibility candidate 2 (lncRNA CASC2) is frequently downregulated in several types of tumors and functions as a tumor-suppressive factor. However, the clinical significance and function of CASC2 in human glioma remain largely unknown. The ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S137171

    authors: Wang R,Li Y,Zhu G,Tian B,Zeng W,Yang Y,Li Z

    更新日期:2017-07-11 00:00:00

  • Prevalence and Predictors of Post-Traumatic Stress Disorder and Depression Among Survivors Over 12 Years After the Bam Earthquake.

    abstract:Purpose:The Bam earthquake was one of Iran's worst natural disasters. As a reason of limited sample size, prevalence and risk factors of PTSD and depression were still unclear after a huge earthquake in Bam. Patients and Methods:A total of 1500 participants selected from the survivors by multistage sampling. Instrumen...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S252730

    authors: Divsalar P,Dehesh T

    更新日期:2020-05-12 00:00:00

  • Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study.

    abstract::During treatment of acute-phase schizophrenia, attention needs to be given to physical as well as psychological symptoms. It is often difficult, however, to obtain information on physical symptoms from patients with psychomotor excitation, and only laboratory examinations can provide objective data. The results of lab...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s11319

    authors: Nagamine T

    更新日期:2010-06-24 00:00:00

  • Cortical gyrification in schizophrenia: current perspectives.

    abstract::The cerebral cortex of the human brain has a complex morphological structure consisting of folded or smooth cortical surfaces. These morphological features are referred to as cortical gyrification and are characterized by the gyrification index (GI). A number of cortical gyrification studies have been published using ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S145273

    authors: Matsuda Y,Ohi K

    更新日期:2018-07-19 00:00:00

  • Focus group reflections on the current and future state of cognitive assessment tools in geriatric health care.

    abstract:OBJECTIVE:This study provides insight into the thoughts and opinions of geriatric health-care professionals toward cognitive assessments and the use of emerging technologies, such as eye-tracking, to supplement current tools. METHODS:Two focus group sessions were conducted with nurses and physicians who routinely admi...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S82881

    authors: Whitehead JC,Gambino SA,Richter JD,Ryan JD

    更新日期:2015-06-12 00:00:00